Measurement of molecular flux rates by quantifying isotopologue abundances using high resolution mass spectrometry
EP3347713A2
Measurement of protein molecular flux rates by quantifying isotopologue abundances in immonium ion fragments using high resolution mass spectrometry
WO2016044665A1
Kinetics biomarkers for neurodegeneration
US2016074473A1
Effect of phospholipid composition of reconstituted hdl on its cholesterol efflux and anti-inflammatory properties
AU2014232869A1
Methods for monitoring the effects of an agent in sujects with motoneuron disease with dementia
AU2012249301A1
Chemical modification of apolipoprotein mimetic peptides for the production of therapeutic agents
CA2728766A1
Compositions for the treatment of fibrotic diseases or conditions
CA2725138A1
Compositions and methods of treatment using modulators of motoneuron diseases
WO2007106862A2
The use of statins to stimulate neurogenesis
US2008027031A1
Retinoids and Related Compounds for the Treatment of Neuroinflammatory Conditions, Diseases and Disorders
US2009197279A1
Microtubule synthesis as a biomarker
WO2007030523A2
Kinetic biomarker for quantification of lymphoproliferation, clonal expansion, recruitment and trafficking in lymphoid tissues and of the in vivo actions of antigens and modulating agents thereon
AU2005271264A1
Method for measuring dynamics of self-assembling systems of biological molecules in vivo and uses for discovering or evaluating therapeutic agents
WO2005098024A1
In vivo measurement of the relative fluxes through ribonucleotide reductase vs. deoxyribonucleoside pathways using isotopes
